CORT
Corcept Therapeutics Incorporated
$40.83
+$2.47(+6.44%)
36
Overall
25
Value
25
Tech
60
Quality
Market Cap
$8.73B
Volume
1.38M
52W Range
$32.99 - $117.33
Target Price
$94.20
EPS Estimates Overview
| Current Quarter | $0.27 | Next Quarter | $-0.26 |
| Current Year | $0.89 | Next Year | $0.84 |
| QoQ Growth | -196.3% | YoY Growth | -5.6% |
| 3Y EPS CAGR | +11.7% | Target Price | $94.20 |
| Consensus | Buy | Upside | +130.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CORT | $40.83 | +6.4% | 1.38M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corcept Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW